Corporate GovernanceJul 21, 2026, 12:41 PM
Charming Medical Abolishes Dual-Class Shares, Adopts US Governance
AI Summary
Charming Medical Ltd. announced significant corporate governance changes, including its election to no longer rely on foreign private issuer exemptions from Nasdaq's corporate governance requirements. The company will now comply with all Nasdaq rules applicable to U.S. domestic issuers. Additionally, the company is abolishing its dual-class share structure, with Ms. Wong surrendering all 2,000,000 Class B ordinary shares, which carried 20 votes each, for no consideration. This will reduce Ms. Wong's aggregate voting power from approximately 91.25% to 68.19%, ensuring one vote per share for all shareholders.
Key Highlights
- Charming Medical will no longer rely on Nasdaq's foreign private issuer exemptions.
- Company will comply with all Nasdaq corporate governance rules for US domestic issuers.
- Ms. Wong will surrender all 2,000,000 Class B ordinary shares for no consideration.
- Class B ordinary shares carried twenty (20) votes each.
- Ms. Wong's aggregate voting power will decrease from approximately 91.25% to 68.19%.
- Following cancellation, no Class B shares will remain, and each share will have one vote.
- Company will have 15,178,000 Ordinary Shares issued and outstanding post-cancellation.
- Ms. Wong will hold 10,350,360 Ordinary Shares after the changes.
Price Impact
More from MCTA